My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

66.74 -0.75 (-1.11%)
Streaming Delayed Price Updated: 11:42 AM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection. 
Via Benzinga
Topics Product Recall
Assessing Hologic: Insights From 10 Financial Analysts
 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
 
Via Benzinga
Critical Insights From Hologic Analyst Ratings: What You Need To Know
 
Via Benzinga
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally... 
Via Benzinga
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
From Hologic, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
 
Via Benzinga
Peering Into Hologic's Recent Short Interest
 
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years
 
Via Benzinga
Analyst Scoreboard: 8 Ratings For Hologic
 
Via Benzinga
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Hologic, Inc.
Via Business Wire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today
 
Via Benzinga
GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Hologic Analysts Boost Their Forecasts After Q3 Results
 
Via Benzinga
The Analyst Verdict: Hologic In The Eyes Of 8 Experts
 
Via Benzinga
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings reports and the Federal Open Market Committee meeting. 
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
 
Via Benzinga
Peering Into Hologic's Recent Short Interest
 
Via Benzinga
Hologic Announces Financial Results for Third Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events. 
Via Benzinga
Topics Economy
Hologic Completes Acquisition of Endomagnetics Ltd
From Hologic, Inc.
Via Business Wire
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation 
Via News Direct
Topics Lawsuit
72 Million American Women Have Skipped or Delayed Vital Screenings
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024
From Hologic, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.